Wendy Wee serves as Executive at Kindred Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Wendy Wee has executed 13 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 27, 2021 involved selling 78,613 shares valued at $727.2K.
Wendy Wee currently holds 49,039 shares of Kindred Biosciences, Inc. (KIN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Wendy Wee has been a net neutral trader of KIN stock. They have purchased $0 and sold $0 worth of shares.
Wendy Wee's most recent insider trade was on Aug 27, 2021, when they sold 78,613 shares at $9.25 per share.
Get notified when new Form 4 filings are submitted
| $4.93 |
| Discretionary |
| Jan 22, 2021 | KIN | $20.0K | Payment | 4,062 | $4.93 | Discretionary |
| Jan 22, 2021 | KIN | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| Jan 17, 2021 | KIN | $16.8K | Payment | 3,385 | $4.95 | Discretionary |
| Jan 17, 2021 | KIN | $0 | Option Exercise | 6,250 | $N/A | Discretionary |
| Jan 23, 2020 | KIN | $20.7K | Payment | 2,145 | $9.66 | Discretionary |
| Jan 22, 2020 | KIN | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| Jan 22, 2020 | KIN | $24.3K | Payment | 2,460 | $9.88 | Discretionary |
| Jan 23, 2019 | KIN | $21.3K | Payment | 2,138 | $9.95 | Discretionary |
| Jan 22, 2019 | KIN | $28.0K | Payment | 2,768 | $10.12 | Discretionary |
| Jan 22, 2019 | KIN | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| Jan 23, 2018 | KIN | $20.9K | Payment | 2,282 | $9.15 | Discretionary |